LATEST PSYCHEDELICS STOCKS NEWS

332 views8 min read

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104

Field Trip Health
TORONTO, Sept. 09, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; NASDAQ: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today the lead indications for FT-104, its novel psychedelic compound in development, will be Treatment Resistant Depression (TRD) and Postpartum Depressio... Read More...
114 views3 min read

Pure Extracts Ships Initial Vape Cartridge Order to the Ontario Cannabis Store

Pure Extracts Technologies
VANCOUVER, British Columbia, Sept. 08, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, P... Read More...
Calendar111 views1 min read

Bright Minds Biosciences to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference; Shares Now Eligible for DTC Clearance

Bright Minds Biosciences
VANCOUVER, British Columbia, Sept. 08, 2021 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, and Dr. ... Read More...
115 views6 min read

Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility

Red Light Holland
● Red Light Holland Closes Acquisition of 51% of Acadian Exotic Mushrooms ● The Vendors have agreed to purchase all sales from AEM's entire produce for the next three years at a purchase price of $6 per pound ● AEM will fall under the Red Light Farms division, joining Happy Caps Gourmet Mushroom Farm in Halifax, Nova Scotia and Red Light ... Read More...
Calendar108 views3 min read

MINDCURE to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Mind Cure Health
VANCOUVER, BC, Sept. 8, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, President & CEO of MINDCURE, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held fro... Read More...
Financials118 views6 min read

PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

PharmaTher Holdings
TORONTO, Sept. 07, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today released business highlights and financial results for its fiscal year ended May 31, 2021. Unless otherwise indicated, all amounts in this press release are in Canadian dollar... Read More...
134 views5 min read

Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose

Algernon Pharmaceuticals
VANCOUVER, British Columbia, Sept. 07, 2021 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has confirmed in its own preclinical study, that AP-188 (“N,N-Dimethyltryptamine or “DMT”), increased the ... Read More...
92 views7 min read

Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Red Light Holland
Red Light Holland proudly exports a commercial sale of 1.5 Kilograms of Psilocybe Truffles (500 grams of psilocybe Mexicana, 500 grams of Psilocybe Tampanensis and 500 Grams of Psilocybe Galindoi) grown in the Company's Farm in Horst, Netherlands to its laboratory partner, CCrest Laboratories Inc., a cGMP pharmaceutical laboratory in Mont... Read More...
368 views8 min read

Meet Delic, November 6-7, 2021

Delic Holdings
 Meet Delic, a revolutionary, two-day immersive edutainment experience for the world's leading psychedelic and wellness thought and business leaders will take place at AREA15 in Las Vegas, Nevada VANCOUVER, BC, Sept. 1, 2021 /PRNewswire/ -Delic Holdings Corp. ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellnes... Read More...
370 views2 min read

Aion Therapeutic Provides Notice of Default

Aion Therapeutic
TORONTO, Aug. 31, 2021 - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that it anticipates being late in filing its audited annual financial statements (the "Annual Financial Statements") and related management discussion and analysis ("MD&A") for the year ended April 30, 2021, by the prescribed dea... Read More...
78 views7 min read

Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians

Field Trip Health
The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip’s medical teams for screening, prescribing and administration of ketamine.Training programs will provide both didactic and experiential training to therapists and ... Read More...
866 views3 min read

Pure Extracts Ships Initial Vape and Edible Order to Private Saskatchewan Cannabis Distributor

Pure Extracts Technologies
VANCOUVER, British Columbia, Aug. 26, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...
124 views5 min read

MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics in North America

Mind Cure Health
With its minimum viable product (MVP) release on schedule and on budget, MINDCURE will work with its clinical partners to refine the application before full commercial deployment in Q1 2022. VANCOUVER, BC, Aug. 26, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology ... Read More...
796 views7 min read

Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

Delic Holdings
Board Includes Diverse Medical Professionals: Neuroscientist, Anesthesiologist, Addiction Psychiatrist, Interventional Pain Physician and Others to Serve as Thought Leaders and Advisors for Delic Subsidiaries VANCOUVER, BC, Aug. 26, 2021 - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic ... Read More...
118 views4 min read

Mycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPP

HAVN Life Sciences
Both companies to follow necessary protocols to allow for export of naturally-derived psilocybin from Canada and import into the USMIAMI, Aug. 25, 2021 -- Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life ... Read More...
129 views7 min read

Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States

Allied
KELOWNA, British Columbia, Aug. 25, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has received approval from the Colombian Ministry of Justice to initiate a shipment of 200kgs of extracted CBD distillate product (containing less than 0.3% THC) to the United States. This shipment is specifica... Read More...
1354 views2 min read

Silo Pharma Advances Psychedelic Patent Portfolio

Silo Pharma
Englewood Cliffs NJ, Aug. 25, 2021 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced the filing of three distinct Patent Cooperation Treaty (PCT) patent applications pertaining to the central nervous system delivery of unique anti-inflamma... Read More...
Calendar1183 views5 min read

Mydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis Assets

Mydecine Innovations Group
DENVER, Aug. 24, 2021 -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), is pleased to announce that it has filed and mailed its management information circular (the “Information Circular”) and related meeting and proxy materials for the annual general and special meeting of the shareholders of the ... Read More...
73 views7 min read

Allied Corp. Signs Additional Supply Contracts for the Export of Cannabis Flower and CBD Isolate From Colombia to Australia

Allied
KELOWNA, British Columbia, Aug. 19, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has secured two agreements with one of the Australian medicinal cannabis companies that has received Major Project Status from the Australian Department of Industry, Science and Technology. Allied has signed tw... Read More...
839 views4 min read

Optimi Health Clears Final Base Shelf Prospectus

Optimi Health
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 18, 2021 -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to ... Read More...
737 views6 min read

Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products

Psyence Group
TORONTO and CAPE TOWN, South Africa, Aug. 18, 2021 -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the commencement of online sales and distribution of its premium range of functional mush... Read More...
1447 views4 min read

Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

Mydecine Innovations Group
DENVER, Aug. 18, 2021 -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announces it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, with research to be led by Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, Dr. Matthew W. Johnson, Ph. D. The Johns Hopkins... Read More...
1278 views6 min read

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Revive Therapeutics
Novel discovery and research originated from Universidad Central del Caribe and St. Jude Children’s Research HospitalMedicinal mushroom compound with anticancer activities that have minimal effects on normal cellsShowed superior potency against aggressive breast cancer with potential to treat aggressive malignancies such as triple negativ... Read More...
1426 views11 min read

Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders’ Meeting and Adoption of Shareholder Rights Plan

Cybin
TORONTO, August 16, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on psychedelic pharmaceutical therapies, is pleased to announce that Theresa Firestone has been elected to its board of directors at the Company’s annual and special meeting of shareholders held... Read More...
Financials1226 views43 min read

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Mydecine Innovations Group
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0, its Digital Health Platform to Support the Adoption of Psychedelics into Mental Health and Inner Wellness DENVER, Aug. 16, 2021 -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company... Read More...
1415 views4 min read

Pure Extracts Ships Initial Vape Cart Order to BC Liquor Distribution Branch

Pure Extracts Technologies
VANCOUVER, British Columbia, Aug. 12, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufactur... Read More...
1430 views0 min read

Revive Confirms No Material Undisclosed Information

Revive Therapeutics
TORONTO, Aug. 12, 2021 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces that its management is not aware of any undisclosed material information relatin... Read More...
Financials922 views17 min read

COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021

COMPASS Pathways plc
Highlights:Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021Partnership being developed with leading UK institutions to accelerate psychedelic research and develop new models of mental health care in the UKGuy Goodwin appointed Chief Medical Offi... Read More...
Joint VentureM & A800 views1 min read

Silo Pharma Announces that JV partner Zylo Therapeutics Successfully Completes Initial Inspection for Ketamine Intradermal Research

Silo Pharma
Englewood Cliffs NJ, Aug. 11, 2021 -- Silo Pharma, Inc. (OTCQB:SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that Silo’s joint venture partner, ZYLO Therapeutics, completed its first inspection with the SC Board of Pharmacy and will move forward with the Departmen... Read More...
1395 views8 min read

Delic Labs Scientific Advisor Professor Glenn Sammis Receives Full Professorship at University of British Columbia

Delic Holdings
Professor Sammis takes sabbatical to devote significant time toward developing psilocybin and cannabis intellectual property (IP) for Delic Labs VANCOUVER, BC, Aug. 10, 2021 - Delic Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced Professor Glenn Sammis, Scienti... Read More...
CalendarFinancials750 views4 min read

Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET

Field Trip Health
TORONTO, Aug. 10, 2021 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its first fiscal quarter ended June 30, 2021, after market close on Monday, August 16, 2021. The Compan... Read More...
475 views5 min read

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics
Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution for mental illness, substance abuse and neurological disordersAdvancing to FDA clinical studies for methamphetamine use disorder and stroke TORONTO, Aug. 10, 2021 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RV... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!